A retrospective study evaluating the risk of recurrent VTE, MB, and clinically relevant non-major bleeding (CRNMB) among older patients with VTE initiating apixaban or warfarin
Latest Information Update: 30 Sep 2021
At a glance
- Drugs Apixaban (Primary) ; Warfarin (Primary)
- Indications Venous thromboembolism
- Focus Adverse reactions; Therapeutic Use
- 30 Sep 2021 New trial record
- 27 Sep 2021 Results published in the Advances in Therapy